Navigation Links
Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
Date:1/6/2011

BEIJING, Jan. 6, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the fourth quarter and full year ended December 31, 2010. A conference call to discuss these preliminary sales will be held on January 6, 2011 at 8:00 a.m. Eastern Standard Time (January 6, 2011 at 9:00 pm China Standard Time). The Company will issue its final unaudited fourth quarter and full year 2010 financial results on or about March 31, 2011.

Sinovac expects its fourth quarter 2010 preliminary unaudited sales to be in the range of approximately $7.8 million to $10.8 million and its full year 2010 preliminary unaudited sales to be in the range of $32 million to $35 million.  The shortfall in sales as compared to the revised total 2010 sales expectations issued in October 2010 was attributable to the weaker than expected sales of Anflu and Healive in the private market.

Dr. Weidong Yin, Chairman & CEO, commented, "We faced a challenging external market environment in 2010, which negatively impacted vaccine demand in the private market. As the company grows, we cannot avoid market-related volatility. We believe it is a great experience for Sinovac's fast-growing management team to learn and grow. Recognizing the importance of addressing this market situation, we are undertaking initiatives to adjust our sales strategy. Concurrently, we are continuing to advance our R&D projects with the aim of completing development and launching our new products. Currently, we have sufficient cash on hand to support Company's R&D activities, capacity expansion, potential M&A and international collaborations, which are the company's driving forces for future growth."

The preliminary sales ranges are preliminary unaudited estimates for the fourth quarter and full y
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
2. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
3. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
4. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
5. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
6. Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results
7. Sinovac Holds 2010 Annual Meeting of Shareholders
8. Sinovac Schedules 2010 Annual Meeting of Shareholders
9. Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R)
10. Sinovac Announces Plan to Launch Offering of Common Shares
11. Sinovac Announces Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015 Cardinal Health ... business, a leading global manufacturer of cardiology and endovascular ... billion, net of the present value of tax benefits. ... combination of $1.0 billion in new senior unsecured notes ... expected to close in the United States ...
(Date:3/2/2015)... DUBLIN , March 2, 2015   ... device businesses for a total consideration of up to $1.65 ... Endo also evaluating strategic alternatives for AMS, Women,s Health ... into a global specialty pharmaceuticals business ... today announced it has entered into a definitive agreement with ...
(Date:3/2/2015)... WOODLANDS, Texas , March 2, 2015   ... a biopharmaceutical company focused on developing breakthrough treatments for ... end 2014 financial results on Wednesday, March 4, 2015 ... a conference call and webcast to discuss clinical development ... year end of 2014 at 10:00 a.m. Eastern Time ...
Breaking Medicine Technology:Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 2Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 3Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 4Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 5Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 6Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 7Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 2Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2
... Academy of Neurology Annual Meeting,Show Approximately 50 ... 01, 2007 /PRNewswire/ -- Data from two ... of Neurology (AAN),meeting suggest that an investigational ... is effective as add-on,treatment in patients with ...
... Sleep Interference, INDIANAPOLIS, May 03, 2007 /PRNewswire-FirstCall/ -- ... that in patients with pain,caused by diabetic nerve ... Cymbalta (duloxetine HCl), improvements in,both average daily pain ... sleep interference than in those patients,taking sugar pill. ...
Cached Medicine Technology:New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 2New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 3New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 4New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6
(Date:3/2/2015)... Final Cut Pro X plugin specialists have ... Film Studios. , “The TranStatic Volume 2 plugin gives users ... CEO of Pixel Film Studios. “TranStatic Volume 2 is a ... editors toolbox.” , With TranStatic Volume 2 users can transition ... scrambling effects from Pixel Film Studios. Users have total control ...
(Date:3/1/2015)... As residents and business owners in Southlake, ... Carita Weaver, believe in supporting local organizations and ... Chamber of Commerce, Carroll Independent School District and ... website for Southlake mayoral candidate Laura Hill: ... Hill’s campaign, the website combines images, videos and ...
(Date:3/1/2015)... March 01, 2015 Adults who are ... rates for term or universal policies can now use ... the best life insurance companies for single adults can ... at http://quotespros.com/life-insurance.html . , The rate plans that ... are tied to a number of life protection policies. ...
(Date:3/1/2015)... York, NY (PRWEB) March 01, 2015 ... has grown substantially over the past few weeks in ... LLP are actively filing claims, the Firm announces. ... reflects 7,713 cases in the Bergen County proceeding established ... Inc., compared with a few weeks earlier, when 90 ...
(Date:3/1/2015)... 2015 Theme and plugin developers from ... pack for Final Cut Pro X entitled Transccordion. ... to any FCPX editors project.” Said Christiana Austin, CEO ... tools needed to easily drag and drop their accordion ... many different controls over the parameters of this transition ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2
... N.J., April 1, 2008 Defined Health has,announced ... for its 8th,annual Therapeutic Insight conference. Therapeutic Insight ... 30, 2008, at The Westin New York at ... registration information,along with content and attendee statistics from ...
... Association of,Health Plans (OAHP), the statewide trade association of ... Ohioans, announced the,election of new officers this week., ... chair of OAHP.,Crampton is the Chair of the Board ... serving the Ohio CFC Medicaid program in,the Northwest and ...
... 1, 2008 Core People Resources,today announced a ... Wexford, PA. CCSC provides options in healthcare coverage ... chamber members through,its ChamberChoice portfolio., The partnership ... level of employer services, including comprehensive human resource,outsourcing ...
... 2008 Leading consumer,employer and labor organizations ... physician groups and health insurers on principles,to ... and report the,information to consumers., The ... Tiering Programs" announced today creates a national ...
... Turns Assets from Retirement Plans Into Guaranteed Income ... ... NEW YORK, April 1, 2008 AXA Equitable Life,Insurance ... new variable annuity -- Crossings(SM): My Lifetime,IRA(SM), designed specifically as ...
... Acomplia might help fight coronary disease , , TUESDAY, April 1 ... not help slow atherosclerosis, a buildup of arterial plaque that,s ... trial did not find any evidence that the drug actually ... one measure of plaque build-up in arteries. , Acomplia ...
Cached Medicine News:Health News:Shannon Brownlee, Author of 'Overtreated,' to Keynote at Defined Health's 8th Annual Therapeutic Insight Conference 2Health News:Ohio Association of Health Plans Announces New Officers 2Health News:Core People Partners to Expand Services 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 3Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 4Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 4Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 6Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 7Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 2Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 3
... The Modular Shoulder System* ... surgeons with a comprehensive range ... of individual patient needs. With ... Smith + Nephew offers a ...
... The Bio-Modular, for ... shoulder replacement. Modularity in ... range of sizing and ... with one of the ...
... The Bigliani/Flatow shoulder allows for the ... cases of shoulder replacement surgery. Backed ... and decades of experience, the Bigliani/Flatow ... the natural shoulder's mobility, balance, and ...
Comprehensive, unified system for total or hemi shoulder arthroplasty....
Medicine Products: